8MN-24407-10337
4 vaccinations
6 coded responses
50 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 982 / WA
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
CYB-24455-15425
Child or adolescent in my care · Female · 2022-11-10
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Moderna
- 2021-01-16
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-06
-
2021-02-12
Dose 2 — Moderna
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
-
2021-03-05
Survey response — day 21, dose 2MedDRA: Axillary pain — Feeling: GoodFree text: Right axillary painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2021-11-26
Dose 3 — Moderna
-
2021-11-27
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-10
-
2021-12-17
Survey response — day 21, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Missed periodMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Survey response — day 28, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Missed periodMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Survey response — day 35, dose 3MedDRA: Menstruation irregular — Feeling: GoodFree text: Missed periodMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Survey response — day 42, dose 3MedDRA: Amenorrhoea — Feeling: GoodFree text: Have not had a period since my boosterMedDRA releases: 2024-11 · check-in free text available
-
2022-02-26
Survey response — 3 months, dose 3MedDRA: Anembryonic gestation, Uterine dilation and curettage — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Anembryonic pregnancy · Healthcare visit (other): D&C 1-27-22MedDRA releases: 2024-11 · check-in free text available
-
2022-02-26
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-28
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2022-05-27
-
2022-11-10
Dose 4 — Moderna
- 2022-11-10
-
2022-11-11
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-11-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-11-15
- 2022-11-16
- 2022-11-17
- 2022-11-24
- 2022-12-01
- 2022-12-08
- 2022-12-15
- 2022-12-22
- 2023-02-09
- 2023-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-11-26 | Moderna | No |
| 4 | 2022-11-10 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-17 | priority 2/3 | |
| 2022-02-26 | Successful 2022-02-28 |
Reported to VAERS voluntarily prior to GDIT contact |
Free text
Release 5 — day 21, dose 2
Symptoms: Right axillary pain
Release 10 — day 21, dose 3
Symptoms: Missed period
Release 10 — day 28, dose 3
Symptoms: Missed period
Release 10 — day 35, dose 3
Symptoms: Missed period
Release 10 — day 42, dose 3
Symptoms: Have not had a period since my booster
Release 11 — 3 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Amenorrhoea | · | · | ✓ |
| SD | Anembryonic gestation | · | · | ✓ |
| SD | Axillary pain | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release